Global Virology II - HIV and NeuroAIDS /

Saved in:
Bibliographic Details
Imprint:New York : Springer, 2017.
Description:1 online resource
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11384480
Hidden Bibliographic Details
Varying Form of Title:HIV and NeuroAIDS
Other authors / contributors:Shapshak, Paul, editor.
Levine, Andrew J., editor.
Foley, Brian T., editor.
Somboonwit, Charurut, editor.
Singer, Elyse, editor.
ISBN:9781493972906
1493972901
9781493972883
149397288X
Digital file characteristics:text file PDF
Notes:Includes bibliographical references and index.
Print version record.
Summary:This book on NeuroAIDS, a collection of chapters written by experts and specialists from around the world, provides a global perspective on HIV and NeuroAIDS in the field, clinic, and laboratory. The chapters address the comorbidity of HIV and other infectious agents, including Zika virus, Ebola, Chagas disease, TB and HCV. Also discussed are key topics, such as: Molecular socioepidemiology, Global HIV and NeuroAIDS, Neuropathology, cART and blood-brain barrier penetration, HIV replicative oscillations, HIV and SIV evolution, Psychiatric comorbidities, Neurosyphilis, The examination of current and innovative models of translational research to translational effectiveness.
Other form:Print version: 9781493972883 149397288X
Standard no.:10.1007/978-1-4939-7290-6
Table of Contents:
  • Chapter 1. Multidisciplinary Approach to HIV/AIDS: Historical Perspective
  • Chapter 2. Global Issues in NeuroAIDS
  • Chapter 3. HIV-1 related Central Nervous System Diseases: Pathogenesis, Diagnosis, and Treatment
  • An Indian Scenario
  • Chapter 4. HIV-1 Diversity in Brazil
  • Chapter 5. HIV and SIV Evolution
  • Chapter 6. Human Brain Imaging in HIV and NeuroAIDS
  • Chapter 7. HIV Neuroinvasion
  • Chapter 8. Neuropathology of HIV-1 Disease
  • Chapter 9. HIV-related Peripheral Nervous System Illness
  • Chapter 10. The Role of Early Life Programming in Vulnerability and Resilience in Relation to HIV
  • Chapter 11. Neurocognition in Viral Suppressed HIV-Infected Children
  • Chapter 12. Psychiatric Comorbidities in HIV-Infection
  • Chapter 13. Toward an Iterative Approach to Preventing HIV Risk Among Young MSM
  • Chapter 14. NeuroAIDS in Drug Abusers: Associations with Oral Manifestations
  • Chapter 15. Socioepidemiology of Injection Drug Users in Miami and HIV-1B Envelope (V1-V5) Genetic Diversity: A Preliminary Study
  • Chapter 16. The persistence of HIV associated neurocognitive disorder (HAND) in the era of combined antiretroviral therapy (cART)
  • Chapter 17. Antiretroviral Therapy: Brain Penetration
  • Chapter 18. Molecular Mechanisms of Cognitive Impairment in Patients with HIV Infection: Application of Bioinformatics and Data-Mining
  • Chapter 19. Genetic, Epigenetic, and Transcriptomic Studies of NeuroAIDS
  • Chapter 20. NeuroAIDS: A Review of Gene Expression in Neurons, Astrocytes and Oligodendrocytes
  • Chapter 21. Neuronal Apoptotic Pathways in HIV Associated Dementia, Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease
  • Chapter 22. Clinical Relevance of Humanized Mice
  • Chapter 23. HIV and Stroke
  • Chapter 24. Hepatitis C and HIV Neurological Implications
  • Chapter 25. Central Nervous System Reactivation of Chagas Disease in Immuno-compromised Patients with HIV/AIDS
  • Chapter 26. Central Nervous System Tuberculosis
  • Chapter 27. Neurosyphilis and HIV infection
  • Chapter 28. Orthopoxviruses and Human Disease
  • Chapter 29. Opportunistic Neurologic Infections in Patients Infected with Human Immunodeficiency Virus
  • Chapter 30. Zika Virus and HIV/AIDS
  • Chapter 31. Global Convergent Translational Science for Neuro-Involvement in Ebola Viral Disease: Lessons Learned from Neuro-AIDS
  • Chapter 32. Sequence Accuracy in Primary Databases: A case study on HIV-1B
  • Chapter 33. Amyloidogenic Pattern Prediction of HIV-1 Proteins
  • Chapter 34. On the Potential for Multiscale Oscillatory Behavior in HIV
  • Chapter 35. Short oligopeptide T-cell epitopes in HIV-1/AIDS vaccine development: Current status, design, promises and challenges
  • Chapter 36. HIV-1 Envelope (ENV) GP160 trimer protein complex SPIKE as a recombinant macro-molecular assembly vaccine component candidate: Current opinion
  • Chapter 37. Gene Therapy Blueprints for NeuroAIDS
  • Chapter 38. Biostatistical Concerns in HIV Research.